✦ LIBER ✦

Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials

✍ Scribed by Jeffrey O Urieto; TieFu Liu; Jennifer H Black; Kimberley A Cohen; Philip D Hall; Mark C Willingham; Lewis K Pennell; Donna E Hogge; Robert J Kreitman; Arthur E Frankel

Book ID: 116827737
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 413 KB
Volume: 33
Category: Article
ISSN: 1046-5928
DOI: 10.1016/j.pep.2003.09.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-Level Expression and Purification o

High-Level Expression and Purification of the Recombinant Diphtheria Fusion Toxin DTGM for PHASE I Clinical Trials

✍ Arthur E. Frankel; Jason Ramage; Amy Latimer; Theodore Feely; Stephen Delatte; P 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Characterization of variant diphtheria t

Characterization of variant diphtheria toxin–interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials

✍ Yunpeng Su; Shi-Yan Li; Sunil Ghosh; Janelle Ortiz; Donna E. Hogge; Arthur E. Fr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 735 KB

Expression of the Necator americanus hoo

Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials

✍ Gaddam Narsa Goud; Maria Elena Bottazzi; Bin Zhan; Susana Mendez; Vehid Deumic; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 306 KB